Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1

Journal of Lipid Research

Volumn 45, Issue 9, 2004, Pages 1716-1723

  Beulens, J W J ^a,b   Sierksma, A ^a   Van Tol, A ^c   Fournier, N ^d   Van Gent, T ^c   Paul, J L ^d   Hendriks, H F J ^a  

^a TNO   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Body mass index; Fu5AH cells; J774 macrophages; Pre high density lipoprotein; Reverse cholesterol transport; Supplementary key words ATP binding cassette transporter 1

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; DIET; FLUID INTAKE; HUMAN; HUMAN CELL; LEAN BODY WEIGHT; MACROPHAGE; OBESITY; PRIORITY JOURNAL; WHISKEY;

AGED; ALCOHOL DRINKING; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BODY MASS INDEX; CELL LINE; CHOLESTEROL; CROSS-OVER STUDIES; DIET; HUMANS; LIPIDS; LIPOPROTEINS; LIPOPROTEINS, HDL; MACROPHAGES; MALE; MICE; MIDDLE AGED; OBESITY; THINNESS;

EID: 4644351308     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M400109-JLR200     Document Type: Article

References (42)

1. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362: 801-809.
2. Grobee, D. E., E. B. Rimm, U. Keil, and S. Renaud. 1999. Alcohol and the cardiovascular system. In Health Issues Related to Alcohol Consumption. I. MacDonald, editor. Blackwell Science, Oxford. 125-179.
3. Hendriks, H. F., J. Veenstra, E. J. Velthuis-te Wierik, G. Schaafsma, and C. Kluft. 1994. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. BMJ. 308: 1003-1006.
4. Pikaar, N. A., M. Wedel, E. J. van der Beek, W. van Dokkum, H. J. Kempen, C. Kluft, T. Ockhuizen, and R. J. Hermus. 1987. Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids. Metabolism. 36: 538-543.
5. Castelli, W. P., J. T. Doyle, T. Gordon, C. G. Hames, M. C. Hjortland, S. B. Hulley, A. Kagan, and W. J. Zukel. 1977. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet. 2: 153-155.
6. Criqui, M. H., L. D. Cowan, H. A. Tyroler, S. Bangdiwala, G. Heiss, R. B. Wallace, and R. Cohn. 1987. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results from the Lipid Research Clinics Follow-up Study. Am. J. Epidemiol. 126: 629-637.
7. Hendriks, H. F., J. Veenstra, A. van Tol, J. E. Groener, and G. Schaafsma. 1998. Moderate doses of alcoholic beverages with dinner and postprandial high density lipoprotein composition. Alcohol Alcohol. 33: 403-410.
8. van der Gaag, M. S., A. van Tol, L. M. Scheek, R. W. James, R. Urgert, G. Schaafsma, and H. F. Hendriks. 1999. Daily moderate alcohol consumption increases serum paraoxonase activity: a diet-controlled, randomised intervention study in middle-aged men. Atherosclerosis. 147: 405-410.
9. van Tol, A., M. S. van der Gaag, L. M. Scheek, T. van Gent, and H. F. Hendriks. 1998. Changes in postprandial lipoproteins of low and high density caused by moderate alcohol consumption with dinner. Atherosclerosis. 141 (Suppl. 1): 101-103.
10. Mackness, B., M. I. Mackness, S. Arrol, W. Turkie, and P. N. Durrington. 1998. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett. 423: 57-60.
11. Mackness, M. I., S. Arrol, B. Mackness, and P. N. Durrington. 1997. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation. Lancet. 349: 851-852.
12. Fielding, C. J., and P. E. Fielding, 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
13. Owen, J. S., and J. V. Mulcahy, 2002. ATP-binding cassette A1 protein and HDL homeostasis. Atheroscler. Suppl. 3: 13-22.
14. Rothblat, G. H., M. Llera-Moya, V. Atger, G. Kellner-Weibel, D. L. Williams, and M. C. Phillips. 1999. Cell cholesterol efflux: integration of old and new observations provides new insights. J. Lipid Res. 40: 781-796.
15. van der Gaag, M. S., A. van Tol, S. H. Vermunt, L. M. Scheek, G. Schaafsma, and H. F. Hendriks. 2001. Alcohol consumption stimulates early steps in reverse cholesterol transport. J. Lipid Res. 42: 2077-2083.
16. Singaraja, R. R., C. Fievet, G. Castro, E. R. James, N. Hennuyer, S. M. Clee, N. Bissada, J. C. Choy, J. C. Fruchart, B. M. McManus, B. Staels, and M. R. Hayden. 2002. Increased ABCA1 activity protects against atherosclerosis. J. Clin. Invest. 110: 35-42.
17. Fournier, N., O. Francone, G. Rothblat, D. Goudouneche, M. Cambillau, G. Kellner-Weibel, P. Robinet, L. Royer, N. Moatti, A. Simon, and J. L. Paul. 2003. Enhanced efflux of cholesterol from ABCAI-expressing macrophages to serum from type IV hypertriglyceridemic subjects. Atherosclerosis. 171: 287-293.
18. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
19. Groener, J. E., R. W. Pelton, and G. M. Kostner. 1986. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin. Chem. 32: 283-286.
20. Speijer, H., J. E. Groener, E. van Ramshorst, and A. van Tol. 1991. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis. 90: 159-168.
21. van Venrooij, F. V., R. P. Stolk, J. D. Banga, T. P. Sijmonsma, A. van Tol, D. W. Erkelens, and G. M. Dallinga-Thie. 2003. Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes. Diabetes Care. 26: 1216-1223.
22. Joles, J. A., N. Willekes-Koolschijn, L. M. Scheek, H. A. Koomans, T. J. Rabelink, and A. van Tol. 1994. Lipoprotein phospholipid composition and LCAT activity in nephrotic and analbuminemic rats. Kidney Int. 46: 97-104.
23. Fournier, N., V. Atger, J. L. Paul, M. Sturm, N. Duverger, G. H. Rothblat, and N. Moatti. 2000. Human apoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum. Arterioscler. Thromb. Vasc. Biol. 20: 1283-1292.
24. Fournier, N., A. Cogny, V. Atger, D. Pastier, D. Goudouneche, A. Nicoletti, N. Moatti, J. Chambaz, J. L. Paul, and A. D. Kalopissis. 2002. Opposite effects of plasma from human apolipoprotein A-Il transgenic mice on cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells. Arterioscler. Thromb. Vasc. Biol. 22: 638-643.
25. Sakr, S. W., D. L. Williams, G. W. Stoudt, M. C. Phillips, and G. H. Rothblat. 1999. Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP. Biochim. Biophys. Acta. 1438: 85-98.
26. de la Llera Moya, M. M., V. Atger, J. L. Paul, N. Fournier, N. Moatti, P. Giral, K. E. Friday, and G. Rothblat. 1994. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler. Thromb. 14: 1056-1065.
27. Ji, Y., B. Jian, N. Wang, Y. Sun, M. L. Moya, M. C. Phillips, G. H. Rothblat, J. B. Swaney, and A. R. Tall. 1997. Scavenger receptor B1 promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272: 20982-20985.
28. Yancey, P. G., M. A. Kawashiri, R. Moore, J. M. Glick, D. L. Williams, M. A. Connelly, D. J. Rader, and G. H. Rothblat. 2004. In vivo modulation of HDL phospholipid has opposing effects on SR-B1- and ABCA1-mediated cholesterol efflux. J. Lipid Res. 45: 337-346.
29. Marmillot, P., M. N. Rao, Q. H. Liu, S. J. Chirtel, and M. R. Lakshman. 2000. Effect of dietary omega-3 fatty acids and chronic ethanol consumption on reverse cholesterol transport in rats. Metabolism. 49: 508-512.
30. Avdulov, N. A., S. V. Chochina, U. Igbavboa, and W. G. Wood. 2000. Cholesterol efflux to high-density lipoproteins and apolipoprotein A-I Phosphatidylcholine complexes is inhibited by ethanol: role of apolipoprotein structure and cooperative interaction of phosphatidylcholine and cholesterol. Biochemistry. 39: 10599-10606.
31. Senault, C., D. Betoulle, G. Luc, P. Hauw, D. Rigaud, and F. Fumeron. 2000. Beneficial etlbcls of a moderate consumption of red wine on cellular cholesterol efflux in young men. Nutr. Metab. Cardiovasc. Dis. 10: 63-69.
32. Hara, H., and S. Yokoyama. 1991. Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J. Biol. Chem. 266: 3080-3086.
33. Yancey, P. G., J. K. Bielicki, W. J. Johnson, S. Lund-Katz, M. N. Palgunachari, G. M. Anantharamaiah, J. P. Segrest, M. C. Phillips, and G. H. Rothblat. 1995. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry. 34: 7955-7965.
34. Barrans, A., B. Jaspard, R. Barbaras, H. Chap, B. Perret, and X. Collet. 1996. Pre-beta HDL: structure and metabolism. Biochim. Biophys. Acta. 1300: 73-85.
35. Lie, J., R. de Crom, M. Jauhiainen, T. van Gent, R. van Haperen, L. Scheek, H. Jansen, C. Ehnholm, and A. van Tol. 2001. Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteins. Biochem. J. 360: 379-385.
36. Pussinen, P. J., M. Jauhiainen, and C. Ehnholm. 1997. ApoA-II/apoA-I molar ratio in the HDL particle influences phospholipid transfer protein-mediated HDL interconversion. J. Lipid Res. 38: 12-21.
37. Sparks, D. L., P. G. Frank, S. Braschi, T. A. Neville, and Y. L. Marcel. 1999. Effect of apolipoprotein A-1 lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles. Biochemistry. 38: 1727-1735.
38. Atger, V., M. M. de la Llera, M. Bamberger, O. Francone, P. Cosgrove, A. Tall, A. Walsh, N. Moatti, and G. Rothblat. 1995. Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein A-I. J. Clin. Invest. 96: 2613-2622.
39. Fournier, N., M. M. de la Llera, B. F. Burkey, J. B. Swaney, J. Paterniti, Jr., N. Moatti, V. Atger, and G. H. Rothblat. 1996. Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats. J. Lipid Res. 37: 1704-1711.
40. Brites, F. D., C. D. Bonavita, C. De Geitere, M. Cloes, B. Delfly, M. J. Yael, J. Fruchart, R. W. Wikinski, and G. R. Castro. 2000. Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels. Atherosclerosis. 152: 181-192.
41. Sasahara, T., P. Nestel, N. Fidge, and D. Sviridov. 1998. Cholesterol transport between cells and high density lipoprotein subfractions from obese and lean subjects. J. Lipid Res. 39: 544-554.
42. Syvänne, M., G. Castro, C. Dengremont, C. De Geitere, M. Jauhiainen, C. Ehnholm, S. Michelagnoli, G. Franceschini, J. Kahri, and M. R. Taskinen. 1996. Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-1: A-II particles and phospholipid transfer protein. Atherosclerosis. 127: 245-253.